Gynostemma pentaphyllum for dyslipidemia: A systematic review of randomized controlled trials
Objective: To evaluate the lipid-lowering effect and safety of Gynostemma pentaphyllum (GP) used alone or as adjunctive therapy for dyslipidemia.Methods: Eight databases and three clinical trial registries were searched until January 2022. Randomized controlled trials (RCTs) assessing the effectiven...
Saved in:
Main Authors: | Ning Dai (Author), Fang-fang Zhao (Author), Min Fang (Author), Feng-lan Pu (Author), Ling-yao Kong (Author), Jian-ping Liu (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2022-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Protective effect of heat-processed Gynostemma pentaphyllum on high fat diet-induced glucose metabolic disorders mice
by: Jin-Bo Xie, et al.
Published: (2023) -
Structural modulation of gut microbiota during alleviation of non-alcoholic fatty liver disease with Gynostemma pentaphyllum in rats
by: Shu-Hua Shen, et al.
Published: (2020) -
New natural protein tyrosine phosphatase 1B inhibitors from Gynostemma pentaphyllum
by: Xianting Wang, et al.
Published: (2024) -
Anti-atherosclerotic effects of Camellia chrysantha and Gynostemma pentaphyllum extracts mixture
by: Hong Hanh Nguyen, et al.
Published: (2023) -
Network pharmacology analysis reveals neuroprotection of Gynostemma pentaphyllum (Thunb.) Makino in Alzheimer' disease
by: Jiahao Wang, et al.
Published: (2022)